Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 16 Carcinoma, Non-Small-Cell Lung 7 Ovarian Neoplasms 5 Uterine Cervical Neoplasms 4 Stomach Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Pancreatic Intraductal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Thrombosis 1 Stage IA Uterine Sarcoma 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Solid Tumor Cancer 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Peripheral Nervous System Diseases 1 Pancreatic Cyst 1 Pain 1 Organoid 1 Neoplasms, Germ Cell and Embryonal 1 NSCLC 1 Motor Activity 1 Medulloblastoma 1 Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer 1

Interventions

trifluridine tipiracil drug combination 1 tipiracil 1 Trifluridine 1 TP protocol 1 Pemetrexed 1 Paclitaxel 1 PE regimen 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Solid Tumor Cancer × Paclitaxel × Clear all

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡